Billadeau DD - Search Results

1

SIRT1-Activating Compounds (STAC) Negatively Regulate Pancreatic Cancer Cell Growth and Viability Through a SIRT1 Lysosomal-Dependent Pathway.

Chini CC, Espindola-Netto JM, Mondal G, Guerrico AM, Nin V, Escande C, Sola-Penna M, Zhang JS, Billadeau DD, Chini EN. Chini CC, et al. Among authors: billadeau dd. Clin Cancer Res. 2016 May 15;22(10):2496-507. doi: 10.1158/1078-0432.CCR-15-1760. Epub 2015 Dec 11. Clin Cancer Res. 2016. PMID: 26655844 Free PMC article.

2

Introduction of an activated N-ras oncogene alters the growth characteristics of the interleukin 6-dependent myeloma cell line ANBL6.

Billadeau D, Jelinek DF, Shah N, LeBien TW, Van Ness B. Billadeau D, et al. Cancer Res. 1995 Aug 15;55(16):3640-6. Cancer Res. 1995. PMID: 7627974

3

Activating mutations in the N- and K-ras oncogenes differentially affect the growth properties of the IL-6-dependent myeloma cell line ANBL6.

Billadeau D, Liu P, Jelinek D, Shah N, LeBien TW, Van Ness B. Billadeau D, et al. Cancer Res. 1997 Jun 1;57(11):2268-75. Cancer Res. 1997. PMID: 9187131

4

Ectopic expression of VAV1 reveals an unexpected role in pancreatic cancer tumorigenesis.

Fernandez-Zapico ME, Gonzalez-Paz NC, Weiss E, Savoy DN, Molina JR, Fonseca R, Smyrk TC, Chari ST, Urrutia R, Billadeau DD. Fernandez-Zapico ME, et al. Among authors: billadeau dd. Cancer Cell. 2005 Jan;7(1):39-49. doi: 10.1016/j.ccr.2004.11.024. Cancer Cell. 2005. PMID: 15652748 Free article.

5

Glycogen synthase kinase-3beta participates in nuclear factor kappaB-mediated gene transcription and cell survival in pancreatic cancer cells.

Ougolkov AV, Fernandez-Zapico ME, Savoy DN, Urrutia RA, Billadeau DD. Ougolkov AV, et al. Among authors: billadeau dd. Cancer Res. 2005 Mar 15;65(6):2076-81. doi: 10.1158/0008-5472.CAN-04-3642. Cancer Res. 2005. PMID: 15781615

6

Aberrant nuclear accumulation of glycogen synthase kinase-3beta in human pancreatic cancer: association with kinase activity and tumor dedifferentiation.

Ougolkov AV, Fernandez-Zapico ME, Bilim VN, Smyrk TC, Chari ST, Billadeau DD. Ougolkov AV, et al. Among authors: billadeau dd. Clin Cancer Res. 2006 Sep 1;12(17):5074-81. doi: 10.1158/1078-0432.CCR-06-0196. Clin Cancer Res. 2006. PMID: 16951223 Free PMC article.

7

Characterization of the CXCR4 signaling in pancreatic cancer cells.

Billadeau DD, Chatterjee S, Bramati P, Sreekumar R, Shah V, Hedin K, Urrutia R. Billadeau DD, et al. Int J Gastrointest Cancer. 2006;37(4):110-9. doi: 10.1007/s12029-007-0011-7. Int J Gastrointest Cancer. 2006. PMID: 18175225

8

Regulation of pancreatic tumor cell proliferation and chemoresistance by the histone methyltransferase enhancer of zeste homologue 2.

Ougolkov AV, Bilim VN, Billadeau DD. Ougolkov AV, et al. Among authors: billadeau dd. Clin Cancer Res. 2008 Nov 1;14(21):6790-6. doi: 10.1158/1078-0432.CCR-08-1013. Clin Cancer Res. 2008. PMID: 18980972 Free PMC article.

9

Synthesis and biological evaluation of triazol-4-ylphenyl-bearing histone deacetylase inhibitors as anticancer agents.

He R, Chen Y, Chen Y, Ougolkov AV, Zhang JS, Savoy DN, Billadeau DD, Kozikowski AP. He R, et al. Among authors: billadeau dd. J Med Chem. 2010 Feb 11;53(3):1347-56. doi: 10.1021/jm901667k. J Med Chem. 2010. PMID: 20055418 Free PMC article.

10

2B4 utilizes ITAM-containing receptor complexes to initiate intracellular signaling and cytolysis.

Bida AT, Upshaw Neff JL, Dick CJ, Schoon RA, Brickshawana A, Chini CC, Billadeau DD. Bida AT, et al. Among authors: billadeau dd. Mol Immunol. 2011 May;48(9-10):1149-59. doi: 10.1016/j.molimm.2011.02.008. Epub 2011 Mar 25. Mol Immunol. 2011. PMID: 21439641 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

228 results

Search Page